Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Stress Disorders, Post-Traumatic
Interventions
DEVICE

Apollo Wearable

Participants will be provided with the Apollo wearable device and asked to install the study mobile application on their mobile phone. Participants will use the Apollo for at least 30 minutes after waking up in the morning and at least 30 minutes before bed on the corresponding settings for those times of day. They will be given the Apollo Device TVS (10-200 Hz) to borrow which they will be instructed to wear everyday. They will be asked to continue to wear the device until all study data is collected.

Trial Locations (1)

15219

RECRUITING

Apollo Neuroscience, Inc., Pittsburgh

Sponsors
All Listed Sponsors
collaborator

The Board of Medicine

OTHER

lead

Apollo Neuroscience, Inc.

INDUSTRY